Q4 2023 · 13F-HR
Kynam Capital Management, LPholdings as filed
Filed 2024-02-14 · accession 0001085146-24-001322
$902.6M
Reported value
24
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 632307104 | NTRA | NATERA INC | $150.3M | 16.7% | 2,400,000 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $122.3M | 13.6% | 5,660,000 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $119.2M | 13.2% | 3,005,904 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $63.0M | 6.97% | 1,002,407 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $56.1M | 6.22% | 3,650,339 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $46.0M | 5.09% | 2,004,875 | Common | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $42.2M | 4.67% | 1,422,503 | Common | SOLE |
| 617760202 | MOR2 | MORPHOSYS AG | $41.9M | 4.64% | 4,234,685 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $34.4M | 3.81% | 5,854,766 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $32.5M | 3.60% | 2,698,324 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $27.6M | 3.05% | 4,600,000 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $25.4M | 2.82% | 5,953,825 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $21.2M | 2.35% | 1,514,383 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $19.9M | 2.20% | 3,932,082 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $19.0M | 2.11% | 585,900 | PUT | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $18.0M | 1.99% | 2,000,000 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $13.2M | 1.47% | 607,915 | Common | SOLE |
| 023111206 | — | AMARIN CORP PLC | $10.5M | 1.16% | 12,022,957 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $9.0M | 0.99% | 1,200,000 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $8.6M | 0.95% | 2,001,727 | Common | SOLE |
| 12233L107 | BNR | BURNING ROCK BIOTECH LTD | $8.1M | 0.90% | 8,694,426 | Common | SOLE |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $6.1M | 0.68% | 1,068,527 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $4.7M | 0.52% | 340,190 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $3.5M | 0.39% | 442,704 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.